tiprankstipranks
Immunovant rallies after Chugai myasthenia gravis study failure
PremiumThe FlyImmunovant rallies after Chugai myasthenia gravis study failure
26d ago
Tourmaline Bio sinks after Chugai myasthenia gravis study failure
PremiumThe Fly
Tourmaline Bio sinks after Chugai myasthenia gravis study failure
26d ago
Argenx rallies after Chugai generalized myasthenia gravis study fails
PremiumThe Fly
Argenx rallies after Chugai generalized myasthenia gravis study fails
26d ago
Roche to hold a virtual neurology analyst and investor event
PremiumThe FlyRoche to hold a virtual neurology analyst and investor event
1M ago
Roche to hold a virtual neurology analyst and investor event
PremiumThe Fly
Roche to hold a virtual neurology analyst and investor event
1M ago
Roche, Alnylam report KARDIA-2 study met primary endpoint
PremiumThe Fly
Roche, Alnylam report KARDIA-2 study met primary endpoint
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100